95 related articles for article (PubMed ID: 6682760)
1. Purification and characterization of a melanoma cell plasminogen activator.
Wallén P; Pohl G; Bergsdorf N; Rånby M; Ny T; Jörnvall H
Eur J Biochem; 1983 May; 132(3):681-6. PubMed ID: 6682760
[TBL] [Abstract][Full Text] [Related]
2. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin.
Wallén P; Bergsdorf N; Rånby M
Biochim Biophys Acta; 1982 Nov; 719(2):318-28. PubMed ID: 6891267
[TBL] [Abstract][Full Text] [Related]
3. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
Einarsson M; Brandt J; Kaplan L
Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
Stump DC; Lijnen HR; Collen D
J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
Rijken DC; Collen D
J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
[TBL] [Abstract][Full Text] [Related]
6. Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneity.
Jörnvall H; Pohl G; Bergsdorf N; Wallén P
FEBS Lett; 1983 May; 156(1):47-50. PubMed ID: 6221944
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
Booyse FM; Osikowicz G; Feder S; Scheinbuks J
J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
[TBL] [Abstract][Full Text] [Related]
8. Purification and partial characterization of plasminogen activator from human uterine tissue.
Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
[TBL] [Abstract][Full Text] [Related]
9. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.
Nielsen LS; Hansen JG; Skriver L; Wilson EL; Kaltoft K; Zeuthen J; Danø K
Biochemistry; 1982 Dec; 21(25):6410-5. PubMed ID: 6891264
[TBL] [Abstract][Full Text] [Related]
10. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
Robbins KC; Tanaka Y
Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
Corti A; Nolli ML; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
[TBL] [Abstract][Full Text] [Related]
12. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
[TBL] [Abstract][Full Text] [Related]
13. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
[TBL] [Abstract][Full Text] [Related]
14. Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.
Andreasen PA; Nielsen LS; Grøndahl-Hansen J; Skriver L; Zeuthen J; Stephens RW; Danø K
EMBO J; 1984 Jan; 3(1):51-6. PubMed ID: 6538482
[TBL] [Abstract][Full Text] [Related]
15. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
16. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.
Collen D; Rijken DC; Van Damme J; Billiau A
Thromb Haemost; 1982 Dec; 48(3):294-6. PubMed ID: 6891842
[TBL] [Abstract][Full Text] [Related]
17. Differences between uterine and melanoma forms of tissue plasminogen activator.
Pohl G; Kaplan L; Einarsson M; Wallén P; Jörnvall H
FEBS Lett; 1984 Mar; 168(1):29-32. PubMed ID: 6538514
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Bykowska K; Rijken DC; Collen D
Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
[TBL] [Abstract][Full Text] [Related]
20. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein.
Roche PC; Campeau JD; Shaw ST
Biochim Biophys Acta; 1983 May; 745(1):82-9. PubMed ID: 6342680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
